Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone
- 9 October 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 881 (1) , 1-8
- https://doi.org/10.1016/s0006-8993(00)02770-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Efficacy in drug receptor theory: outdated concept or under-valued tool?Trends in Pharmacological Sciences, 1999
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptorFEBS Letters, 1995
- Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1FEBS Letters, 1995
- Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brainFEBS Letters, 1994
- Pharmacological Mechanisms of Opioid AnalgesicsClinical Neuropharmacology, 1993
- Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actionsLife Sciences, 1991
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- COMPARISON OF DISSOCIATION CONSTANTS AND OF RELATIVE EFFICACIES OF SELECTED AGONISTS ACTING ON PARASYMPATHETIC RECEPTORS*Annals of the New York Academy of Sciences, 1967